News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Anirban Maitra: Targeting the PI3Ka-RAS interaction axis
Anirban Maitra/X
Dec 23, 2024, 06:00

Anirban Maitra: Targeting the PI3Ka-RAS interaction axis

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center shared on X:

“New preprint from Vividion Therapeutics in collaboration with Julian Downward on targeting the PI3Ka-RAS interaction axis, without the collateral effects on compensatory insulin signaling.
Covalent inhibitors of the RAS binding domain of PI3Ka impair tumor growth driven by RAS and HER2.”

Anirban Maitra: Targeting the PI3Ka-RAS interaction axis

 

Anirban Maitra cancer Julian Downward OncoDaily Oncology Vividion Therapeutics
Special Coverage
Blog
Dec 23, 2024, 06:00
Anirban Maitra: Targeting the PI3Ka-RAS interaction axis
Blog
Dec 23, 2024, 05:56
Megan-Claire Chase: The different layers of advocacy, both in the public eye and behind the scenes
Blog
Dec 23, 2024, 05:49
Shikha Jain: From Burnout to Breakthrough - How These Entrepreneurs Are Empowering Women in Healthcare
Blog
Dec 23, 2024, 05:43
Pashtoon Kasi: City of Hope Buys 52 Acres in Orange County for $89M
Blog
Dec 23, 2024, 05:31
The Leukemia Lymphoma Society - Give today for a brighter tomorrow for those affected by Blood Cancer
Blog
Dec 22, 2024, 18:02
Erman Akkus: Negative hyper-selection for anti-EGFR therapy in mCRC
Insight
Dec 22, 2024, 17:57
Gustavo Viani: Internal Mammary Node Radiation, A Survival Boost for Breast Cancer Patients?
Insight
Dec 22, 2024, 17:54
Stephen Liu: The seminal IPASS trial in EGFR NSCLC
Insight
Dec 22, 2024, 17:51
Angela Lamarca: eUpdate of ESMO Biliary Malignancies CP Guidelines
Insight
Dec 22, 2024, 17:47
Next-gen immunotherapy is reshaping lung cancer treatment
Insight
Dec 22, 2024, 17:44
Erman Akkus: Local treatments of HCC, 2 recent studies
Blog
Dec 22, 2024, 17:39
Mark Cobbold: Incredible Year in Cell Therapy and Immunotherapy at AstraZeneca